-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Depreciation, Depletion and Amortization history and change rate from Q1 2020 to Q1 2025.
- Barinthus Biotherapeutics plc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $2.03M, a 42.2% increase year-over-year.
- Barinthus Biotherapeutics plc. annual Depreciation, Depletion and Amortization for 2024 was $5.8M, a 6.83% increase from 2023.
- Barinthus Biotherapeutics plc. annual Depreciation, Depletion and Amortization for 2023 was $5.43M, a 25.6% increase from 2022.
- Barinthus Biotherapeutics plc. annual Depreciation, Depletion and Amortization for 2022 was $4.32M, a 618% increase from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)